|
CPT1B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.79020132051733E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.39270039944961E-10 |
| Normal-vs-Stage2 |
1.713430E-01 |
| Normal-vs-Stage3 |
8.49239999989315E-07 |
| Normal-vs-Stage4 |
3.241000E-04 |
| Stage1-vs-Stage2 |
1.623880E-02 |
| Stage1-vs-Stage3 |
9.936400E-01 |
| Stage1-vs-Stage4 |
1.888010E-01 |
| Stage2-vs-Stage3 |
3.524000E-02 |
| Stage2-vs-Stage4 |
1.238030E-02 |
| Stage3-vs-Stage4 |
2.131000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.20321588435036E-12 |
| Normal-vs-AfricanAmerican |
3.964100E-03 |
| Normal-vs-Asian |
2.166300E-04 |
| Caucasian-vs-AfricanAmerican |
3.808000E-01 |
| Caucasian-vs-Asian |
8.060800E-01 |
| AfricanAmerican-vs-Asian |
6.473200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.71490005424135E-09 |
| Normal-vs-Female |
5.39290001544401E-09 |
| Male-vs-Female |
2.404400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.19859996875016E-09 |
| Normal-vs-Age(41-60Yrs) |
1.62750000032297E-07 |
| Normal-vs-Age(61-80Yrs) |
9.62369999999435E-05 |
| Normal-vs-Age(81-100Yrs) |
3.723600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.254620E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.223000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.435600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.379000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.030200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.318600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.924000E-02 |
| Classical-VS-Follicular |
3.033900E-02 |
| Classical-VS-Other |
5.403600E-01 |
| Classical-VS-Normal |
2.64710475761376E-12 |
| Tall-VS-Follicular |
6.130200E-01 |
| Tall-VS-Other |
9.592300E-02 |
| Tall-VS-Normal |
1.397060E-04 |
| Follicular-VS-Other |
2.202800E-01 |
| Follicular-VS-Normal |
7.095400E-03 |
| Other-VS-Normal |
2.075500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.62820000499431E-08 |
| Normal-vs-N1 |
1.83333000000063E-05 |
| N0-vs-N1 |
1.495640E-02 |
|
|
